文献速递乳腺乳腺X线USMRPET

低风险导管原位癌治疗范式的演变:影像学需求

Evolving Treatment Paradigms for Low-Risk Ductal Carcinoma In Situ: Imaging Needs.
PubMed 文献 · AJR Am J Roentgenol · 2023-12-13

导管原位癌(DCIS)经典表现为筛查乳腺X线摄影上的无症状钙化,随着筛查项目普及,DCIS诊断增多引发过度诊断担忧,患者对个性化医疗的追求也提高了对过度治疗的关注。大多数新诊断DCIS的标准治疗是手术切除,但通过主动监测进行非手术管理正受到关注,多项临床试验正在进行。影像学联合人口学和病理学信息是主动监测的关键组成部分,常用影像模态包括乳腺X线摄影、超声和MRI,以及对比增强乳腺X线摄影和专用乳腺PET等新模态,可提供预后信息以对患者进行风险分层,放射科医生将负责密切监测主动监测中的患者并识别是否发生浸润性进展。

要点

  • DCIS通常表现为筛查乳腺X线摄影上的无症状钙化,是浸润性癌的非必然前驱病变。
  • 乳腺X线摄影、超声、MRI及对比增强乳腺X线摄影、专用乳腺PET可提供预后信息,用于DCIS主动监测资格的风险分层。
  • 放射科医生在主动监测中负责密切监测患者并识别浸润性进展,其解读和指导对主动监测的成败至关重要。

核心结论

  • 主动监测是DCIS治疗的范式转变,其成功与否将在很大程度上依赖于放射科医生的解读和指导。

研究设计与样本

  • 综述性文章,讨论低风险DCIS治疗范式的演变及影像学在主动监测中的作用。

关键影像表现/征象

  • DCIS经典表现为筛查乳腺X线摄影上的无症状钙化。

诊断标准与关键数值

  • 影像学(乳腺X线摄影、超声、MRI、对比增强乳腺X线摄影、专用乳腺PET)联合人口学和病理学信息可提供预后信息,用于风险分层以评估DCIS主动监测资格。

临床应用与阅片要点

  • 放射科医生将负责密切监测主动监测中的患者,并识别是否发生浸润性进展。
  • 影像学联合人口学和病理学信息是主动监测努力的关键组成部分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Ductal carcinoma in situ (DCIS) is a nonobligate precursor to invasive cancer that classically presents as asymptomatic calcifications on screening mammography. The increase in DCIS diagnoses with organized screening programs has raised concerns about overdiagnosis, while a patientcentric push for more personalized care has increased awareness about DCIS overtreatment. The standard of care for most new DCIS diagnoses is surgical excision, but nonsurgical management via active monitoring is gaining attention, and multiple clinical trials are ongoing. Imaging, along with demographic and pathologic information, is a critical component of active monitoring efforts. Commonly used imaging modalities including mammography, ultrasound, and MRI, as well as newer modalities such as contrast-enhanced mammography and dedicated breast PET, can provide prognostic information to risk stratify patients for DCIS active monitoring eligibility. Furthermore, radiologists will be responsible for closely surveilling patients on active monitoring and identifying if invasive progression occurs. Active monitoring is a paradigm shift for DCIS care, but the success or failure will rely heavily on the interpretations and guidance of radiologists.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Nguyen DL, Greenwood HI, Rahbar H, et al. Evolving Treatment Paradigms for Low-Risk Ductal Carcinoma In Situ: Imaging Needs. AJR Am J Roentgenol. 2023. PMID: 38090808. doi:10.2214/AJR.23.30503

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。